Ireland
--:--IST
Latest
Recruiting Observational

Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy

NCT07445412 · tracked via the Priya Life Science Italy tracker
Phase
Observational
Started
2024-10-22
Last updated
2026-03-03

Condition(s) studied

Liver TumoursLiver Cancer (Primary and Metastatic)Liver ResectionLiver Hypertrophy

Study summary

The goal of this national mutlticenter observational study is to learn and describe trends over time in the use of techniques for inducing hepatic hypertrophy in Italy. Patients will be treated according to the current clinical practice of the participating centers and will be observed from the moment of recruitment and throughout their stay. Information on vital status will be collected, as far as possible, for up to 5 years after surgery in order to record any events that occur in a timely manner. There are also plans to retrospectively collect data on patients who underwent hypertrophic techniques in the previous 10 years, in order to establish a historical cohort for each center that can be used for comparison with the prospective cohort.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients aged 18 or older * Obtaining informed consent * Patients with liver neoplasia (benign or malignant) and with a future liver remnant volume deemed insufficient (\<20%-40%) by the local multidisciplinary team Exclusion Criteria: * pregnant or breastfeeding woman

Primary outcome measure(s)

  • Describe the temporal trends in the use of techniques for inducing hepatic hypertrophy in Italy — through study completion, an average of 1 year
  • compare the techniques used in terms of function and volumetric hypertrophy — through study completion, an average of 1 year
  • compare the techniques used in terms of drop-out — through study completion, an average of 1 year
  • compare the techniques used in terms of 90-day mortality — through study completion, an average of 1 year
  • compare the techniques used in terms of long-term survival — through study completion, an average of 1 year
  • compare the techniques used in terms of disease-free survival — through study completion, an average of 1 year

Trial sites (1)

FacilityCityRegionStatus
IRCCS Azienda Ospedaliero-Universitario di Bologna Bologna Bologna Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07445412 on ClinicalTrials.gov ↗ ← All trials in Italy